Search clinical trials for: programmed cell death-ligand 1 (PD-L1, PDL1)
Total 92333 results
-
Kiang Wu HospitalCompleted
-
BrightPath BiotherapeuticsTerminated
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Peking Union Medical College HospitalRecruiting
-
Phanes TherapeuticsRecruitingNon Small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsGermany
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Jun Zhang, MD, PhDRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Peking University Cancer Hospital & InstituteRecruitingMelanoma | Lung Cancer | PD-L1 | PET/CTChina
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal NeoplasmsChina
-
Poitiers University HospitalActive, not recruitingNon Small Cell Lung Cancer | Gene Mutation-Related Cancer | PD-L1 | PET/CTFrance
-
PfizerTerminatedMelanoma | Soft Tissue Sarcoma | Mycosis Fungoides | Breast Carcinoma | Solid Tumors | Squamous Cell Carcinoma | Human Papillomavirus-Related Malignant Neoplasm | Merkel-cell CarcinomaUnited States
-
Beijing Friendship HospitalNot yet recruiting
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Highlight TherapeuticsTerminatedAdvanced Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | Refractory Hepatocellular CarcinomaUnited States
-
Attikon HospitalUnknownDNA Damage | HNSCC | DNA Double Strand BreakGreece
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedCompletedNon-Small Cell Lung CancerChina
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly
-
National Cancer Institute (NCI)RecruitingSmall Cell Lung Cancer | Lung Cancer | Carcinoma, Small CellUnited States
-
Lars Møller PedersenIO BiotechCompletedChronic Lymphocytic LeukemiaDenmark
-
Peking University First HospitalNot yet recruitingCarcinoma, Hepatocellular
-
Jounce Therapeutics, Inc.Terminated
-
RenJi HospitalNot yet recruitingPediatric Cancer | Liver Cancer | Hepatoblastoma | Pediatric Solid Tumor | Transitional Cell TumorChina
-
Seagen Inc.TerminatedCarcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Carcinoma, Squamous Cell of Head and Neck | Urinary Bladder NeoplasmUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting
-
MultiVir, Inc.UnknownLymphoma | Solid TumorUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Shanghai Chest HospitalRecruitingNon-Small Cell Lung CancerChina
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
Maastricht Radiation OncologyMaastricht University Medical Center; Zuyderland Medical CentreCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Yale UniversityTerminatedAsymptomatic MyelomaUnited States
-
Sohag UniversityNot yet recruitingNasopharyngeal and Hypopharyngeal CarcinomaEgypt
-
Merck Sharp & Dohme LLCRecruitingMelanomaSpain, Poland, United States, Australia, France, Israel, Italy, South Africa, Switzerland, Chile, Greece, Colombia, Hungary, Argentina
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Shanghai Zhongshan HospitalRecruitingAdvanced Gastric CancerChina
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Targovax OyAgenus Inc.Withdrawn
-
NYU Langone HealthEMD SeronoCompleted
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Cancer HospitalHenan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingNon Small Cell Lung CancerChina
-
jianming xuNeoCuraRecruitingGastric Cancer | Esophageal Cancer | Liver CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI); Imugene LimitedActive, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLocally Advanced Cervical CancerFrance
-
Diwakar DavarAculeus TherapeuticsCompletedNSCLC | Metastatic Colorectal Carcinoma | Refractory MelanomaUnited States